CD4 and lung adenocarcinoma: Furthermore, 105 of CD4+ T cells, which were from BALF of both nontumor and tumor sites of 23 stage III lung adenocarcinoma patients, were cultured with anti-CD3 antibody in the presence or absence of GSI.